Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Grant

Showing results (251-260 of 386) with videos related to

Pageof 39
Sort By:
Endocrine-Related Cancer|January 30, 2007
Radiotherapy-induced signal transductionAdly Yacoub, Anna Miller, Ruben W Caron, et al.
Molecular and Cellular Biology|July 9, 2014
Targeting SQSTM1/p62 induces cargo loading failure and converts autophagy to apoptosis via NBK/BikShuang Chen, Liang Zhou, Yu Zhang, et al.
Cell Cycle (Georgetown, Tex.)|January 19, 2005
Radiation-stimulated ERK1/2 and JNK1/2 signaling can promote cell cycle progression in human colon cancer cellsRubén W Carón, Adly Yacoub, Clint Mitchell, et al.
Molecular Pharmacology|June 2, 2009
BCL-2 family inhibitors enhance histone deacetylase inhibitor and sorafenib lethality via autophagy and overcome blockade of the extrinsic pathway to facilitate killingAditi Pandya Martin, Margaret A Park, Clint Mitchell, et al.
Molecular Pharmacology|May 11, 2013
Histone deacetylase inhibitors interact with melanoma differentiation associated-7/interleukin-24 to kill primary human glioblastoma cellsHossein A Hamed, Adly Yacoub, Margaret A Park, et al.
Molecular Cancer Therapeutics|December 11, 2007
Extrinsic pathway- and cathepsin-dependent induction of mitochondrial dysfunction are essential for synergistic flavopiridol and vorinostat lethality in breast cancer cellsClint Mitchell, Maragret A Park, Guo Zhang, et al.
Molecular Cancer Therapeutics|March 14, 2012
Obatoclax interacts synergistically with the irreversible proteasome inhibitor carfilzomib in GC- and ABC-DLBCL cells in vitro and in vivoGirija Dasmahapatra, Dmitry Lembersky, Minkyeong P Son, et al.
Molecular Pharmacology|June 2, 2009
Sorafenib and vorinostat kill colon cancer cells by CD95-dependent and -independent mechanismsTeneille Walker, Clint Mitchell, Margaret A Park, et al.
Bioorganic & Medicinal Chemistry Letters|October 3, 2009
Structure-activity relationship (SAR) studies of 3-(2-amino-ethyl)-5-(4-ethoxy-benzylidene)-thiazolidine-2,4-dione: development of potential substrate-specific ERK1/2 inhibitorsQianbin Li, Adnan Al-Ayoubi, Tailiang Guo, et al.
Molecular Cancer Therapeutics|February 17, 2005
H-RAS V12-induced radioresistance in HCT116 colon carcinoma cells is heregulin dependentRubén W Carón, Adly Yacoub, Xiaoyu Zhu, et al.
Pageof 39

Showing results (251-260 of 386) with videos related to

Sort By:
Pageof 39
Endocrine-Related Cancer|January 30, 2007
Radiotherapy-induced signal transductionAdly Yacoub, Anna Miller, Ruben W Caron, et al.
Molecular and Cellular Biology|July 9, 2014
Targeting SQSTM1/p62 induces cargo loading failure and converts autophagy to apoptosis via NBK/BikShuang Chen, Liang Zhou, Yu Zhang, et al.
Cell Cycle (Georgetown, Tex.)|January 19, 2005
Radiation-stimulated ERK1/2 and JNK1/2 signaling can promote cell cycle progression in human colon cancer cellsRubén W Carón, Adly Yacoub, Clint Mitchell, et al.
Molecular Pharmacology|June 2, 2009
BCL-2 family inhibitors enhance histone deacetylase inhibitor and sorafenib lethality via autophagy and overcome blockade of the extrinsic pathway to facilitate killingAditi Pandya Martin, Margaret A Park, Clint Mitchell, et al.
Molecular Pharmacology|May 11, 2013
Histone deacetylase inhibitors interact with melanoma differentiation associated-7/interleukin-24 to kill primary human glioblastoma cellsHossein A Hamed, Adly Yacoub, Margaret A Park, et al.
Molecular Cancer Therapeutics|December 11, 2007
Extrinsic pathway- and cathepsin-dependent induction of mitochondrial dysfunction are essential for synergistic flavopiridol and vorinostat lethality in breast cancer cellsClint Mitchell, Maragret A Park, Guo Zhang, et al.
Molecular Cancer Therapeutics|March 14, 2012
Obatoclax interacts synergistically with the irreversible proteasome inhibitor carfilzomib in GC- and ABC-DLBCL cells in vitro and in vivoGirija Dasmahapatra, Dmitry Lembersky, Minkyeong P Son, et al.
Molecular Pharmacology|June 2, 2009
Sorafenib and vorinostat kill colon cancer cells by CD95-dependent and -independent mechanismsTeneille Walker, Clint Mitchell, Margaret A Park, et al.
Bioorganic & Medicinal Chemistry Letters|October 3, 2009
Structure-activity relationship (SAR) studies of 3-(2-amino-ethyl)-5-(4-ethoxy-benzylidene)-thiazolidine-2,4-dione: development of potential substrate-specific ERK1/2 inhibitorsQianbin Li, Adnan Al-Ayoubi, Tailiang Guo, et al.
Molecular Cancer Therapeutics|February 17, 2005
H-RAS V12-induced radioresistance in HCT116 colon carcinoma cells is heregulin dependentRubén W Carón, Adly Yacoub, Xiaoyu Zhu, et al.
Pageof 39